Home › Hemophilia › California › Sacramento
Hemophilia clinical trials in Sacramento, CA
4 studies for Hemophilia are looking for participants at sites in and around Sacramento (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
RecruitingPhase 3
- UC Davis Health, Sacramento
- UC Davis Ambulatory Care Clinic, Sacramento
- UC Davis Hemophilia Treatment Center, Sacramento
- and 1 more
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
RecruitingPhase 1/2
- UC Davis Cancer Center, Sacramento
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- University of California at Davis Hemophilia Treatment Center, Sacramento
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
RecruitingPhase 4
- University of California at Davis UC Davis Hemostasis and Thrombosis Center, Sacramento
About Hemophilia
Hemophilia is a rare disorder in which the blood does not clot normally. Usually hemophilia usually occurs in males and is inherited. Learn more.
More about Hemophilia on MedlinePlus
Hemophilia trials in other cities
- Indianapolis, IN9 studies
- Los Angeles, CA7 studies
- Seattle, WA6 studies
- Cedar Rapids, IA6 studies
- Philadelphia, PA5 studies
- Little Rock, AR5 studies
- Tampa, FL4 studies
- Dallas, TX4 studies
- Atlanta, GA4 studies
- Greenville, NC4 studies
- Orange, CA4 studies
- San Francisco, CA3 studies
Other studies in Sacramento
- Non-Small Cell Lung Cancer29 studies
- Lung Cancer22 studies
- Breast Cancer20 studies
- Prostate Cancer19 studies
- Metastatic Cancer16 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure12 studies
- Pancreatic Cancer12 studies
- Cancer (all types)11 studies
- Colon Cancer11 studies
- Bladder Cancer10 studies
- Colorectal Cancer10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.